首页> 美国卫生研究院文献>BMC Pulmonary Medicine >Procalcitonin and lung ultrasonography point-of-care testing to decide on antibiotic prescription in patients with lower respiratory tract infection in primary care: protocol of a pragmatic cluster randomized trial
【2h】

Procalcitonin and lung ultrasonography point-of-care testing to decide on antibiotic prescription in patients with lower respiratory tract infection in primary care: protocol of a pragmatic cluster randomized trial

机译:降钙素原和肺部超声检查的现场检查决定初级护理中下呼吸道感染患者的抗生素处方:一项实用的随机试验方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundA minority of patients presenting with lower respiratory tract infection (LRTI) to their general practitioner (GP) have community-acquired pneumonia (CAP) and require antibiotic therapy. Identifying them is challenging, because of overlapping symptomatology and low diagnostic performance of chest X-ray.Procalcitonin (PCT) can be safely used to decide on antibiotic prescription in patients with LRTI. Lung ultrasound (LUS) is effective in detecting lung consolidation in pneumonia and might compensate for the lack of specificity of PCT.We hypothesize that combining PCT and LUS, available as point-of care tests (POCT), might reduce antibiotic prescription in LRTIs without impacting patient safety in the primary care setting.
机译:背景少数对全科医生(GP)患有下呼吸​​道感染(LRTI)的患者患有社区获得性肺炎(CAP),需要抗生素治疗。由于症状重叠且胸部X线检查的诊断性能低,因此识别它们具有挑战性。降钙素(PCT)可安全地用于确定LRTI患者的抗生素处方。肺超声(LUS)可有效检测肺炎中的肺部巩固,并可能弥补PCT特异性的不足。我们假设将PCT和LUS结合使用,可作为即时检验(POCT),可能会减少LRTI中的抗生素处方影响基层医疗机构的患者安全。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号